Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Chengdu, Sichuan, China

    Main Sales Markets: Central/South America,Eastern Europe,Asia,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: T/T

    Name:

    Human Coagulation Factor IX

    Category:

    Hematology, Critical Illness

    Use within:

    24 months

    Specifications:

    500IU/vial, 10ml after redissolution

    Approval number:

    NMPA Approval No. S20233098

    Indications:

    Used for bleeding treatment in patients aged 12 and above with factor IX deficiency (hemophilia B).

Send your message to this supplier
  • From:
  • To:
    Grand Shuyang Life Sciences (Chengdu) Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service